Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies

Clinical trial NCT01364051 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01364051
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma Refractory Malignant Solid Neoplasm Stage IV Cutaneous Melanoma AJCC v6 and v7 Unresectable Malignant Solid Neoplasm

Start date: 2011-05-25
Primary completion: 2019-06-06
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.